OUTSOURCE
BRCA1 & BRCA2 MUTATION ADVANCED PANEL (N194)
Also Known As:
BRCA1 & BRCA2 MUTATION ADVANCED PANEL
About This Test
Presence of single germline SNPs like BRCA1 & BRCA2 genes increases relative & absolute risk of developing breast cancer & other cancers. Women with this inherited mutated gene allele have 60-80% chance of developing breast cancer & 33% chance of developing ovarian cancer. Breast cancer developing in BRCA1 mutated patients is usually Triple Negative whereas BRCA2 mutated patients are usually ER positive. This assay detects most of the mutations and insertions/deletions in the BRCA gene which is linked to breast cancer. This assay is useful for screening family members of known Breast cancer patients for predisposition.
Test Parameters (1)
- BRCA1 & BRCA2 MUTATION ADVANCED PANEL
Home Collection
✓ Available
Reports Available In
1 Day
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
No special preparation required
This test is important for early detection of cancer risk, preventive planning, and personalized treatment based on BRCA mutations.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
